Insider Transactions in Q3 2020 at Moderna, Inc. (MRNA)
Insider Transaction List (Q3 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Sep 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$648,000
$72.72 P/Share
|
Sep 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,197
-70.41%
|
$1,203,790
$70.2 P/Share
|
Sep 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,197
+43.38%
|
$343,940
$20.04 P/Share
|
Sep 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.7%
|
$740,082
$67.9 P/Share
|
Sep 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$650,000
$65.5 P/Share
|
Sep 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.09%
|
$325,000
$65.33 P/Share
|
Sep 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Sep 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$603,000
$67.99 P/Share
|
Sep 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.26%
|
$1,005,000
$67.27 P/Share
|
Sep 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
Sep 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-62.76%
|
$1,340,000
$67.57 P/Share
|
Sep 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
Sep 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,587
-0.09%
|
$583,916
$68.56 P/Share
|
Sep 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.68%
|
$751,128
$68.16 P/Share
|
Sep 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$680,000
$68.46 P/Share
|
Sep 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Sep 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$603,000
$67.69 P/Share
|
Sep 14
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.26%
|
$1,240,000
$62.13 P/Share
|
Sep 14
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
Sep 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,034
-47.78%
|
$1,242,108
$62.26 P/Share
|
Sep 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,034
+27.88%
|
$360,612
$18.1 P/Share
|
Sep 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.32%
|
$640,668
$58.6 P/Share
|
Sep 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
17,030
-0.1%
|
$953,680
$56.96 P/Share
|
Sep 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Sep 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$495,000
$55.81 P/Share
|
Sep 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,467
-55.96%
|
$1,482,152
$56.32 P/Share
|
Sep 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,467
+28.01%
|
$423,472
$16.63 P/Share
|
Sep 04
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.52%
|
$673,806
$61.91 P/Share
|
Sep 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$650,000
$65.65 P/Share
|
Sep 03
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.51%
|
$650,000
$65.65 P/Share
|
Sep 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
Sep 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.51%
|
$620,000
$62.89 P/Share
|
Sep 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
Sep 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Sep 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$558,000
$62.89 P/Share
|
Sep 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
9,247
-0.1%
|
$582,561
$63.54 P/Share
|
Aug 31
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-67.58%
|
$1,920,000
$64.65 P/Share
|
Aug 31
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.0%
|
$480,000
$16.63 P/Share
|
Aug 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.84%
|
$740,082
$67.06 P/Share
|
Aug 27
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$690,000
$69.91 P/Share
|
Aug 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
Aug 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$603,000
$67.45 P/Share
|
Aug 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-59.42%
|
$1,625,000
$65.45 P/Share
|
Aug 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+34.52%
|
$425,000
$17.43 P/Share
|
Aug 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.2%
|
$1,300,000
$65.43 P/Share
|
Aug 24
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
Aug 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.82%
|
$740,082
$67.06 P/Share
|
Aug 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
18,824
-0.11%
|
$1,261,208
$67.8 P/Share
|
Aug 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|